Quantitation of cell-free DNA in blood is a potential screening and diagnostic maker of breast cancer: a meta-analysis.

about

Quantitation of cell-free DNA in blood is a potential screening and diagnostic maker of breast cancer: a meta-analysis.

Item

http://www.wikidata.org/entity/Q47160671

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Quantitation of cell-free DNA ...... reast cancer: a meta-analysis.

@en

Quantitation of cell-free DNA ...... reast cancer: a meta-analysis.

@nl

type

Item

label

Quantitation of cell-free DNA ...... reast cancer: a meta-analysis.

@en

Quantitation of cell-free DNA ...... reast cancer: a meta-analysis.

@nl

prefLabel

Quantitation of cell-free DNA ...... reast cancer: a meta-analysis.

@en

Quantitation of cell-free DNA ...... reast cancer: a meta-analysis.

@nl

P1476

Quantitation of cell-free DNA ...... reast cancer: a meta-analysis.

@en

P2093

Hongming Pan

http://www.w3.org/2001/XMLSchema#string

Huadi Wang

http://www.w3.org/2001/XMLSchema#string

Jiansheng Xie

http://www.w3.org/2001/XMLSchema#string

Weidong Han

http://www.w3.org/2001/XMLSchema#string

Xiaoyun Zhou

http://www.w3.org/2001/XMLSchema#string

Yong Fang

http://www.w3.org/2001/XMLSchema#string

Zhanggui Wang

http://www.w3.org/2001/XMLSchema#string

Zhen Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Circulating DNA as biomarker in breast cancer

Global cancer statistics, 2012

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis

Effect of three decades of screening mammography on breast-cancer incidence.

Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis.

The plasma DNA concentration as a potential breast cancer screening marker.

The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms

Cell-free DNA in blood is a potential diagnostic biomarker of breast cancer

P304

102336-102345

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.21827

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29254249

http://www.w3.org/2001/XMLSchema#string

P932

5731959

http://www.w3.org/2001/XMLSchema#string